SUBVENITE is a Kit in the Human Prescription Drug category. It is labeled and distributed by Owp Pharmaceuticals, Inc.. The primary component is .
| Product ID | 69102-306_87a84064-9191-4025-bafe-297a6dd86407 |
| NDC | 69102-306 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SUBVENITE |
| Generic Name | Lamotrigine |
| Dosage Form | Kit |
| Marketing Start Date | 2018-04-14 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA078947 |
| Labeler Name | OWP Pharmaceuticals, Inc. |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-04-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA078947 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-04-14 |
| SPL SET ID: | 7ad18b68-ba16-4810-9c3e-27fa970454e8 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69102-306 | SUBVENITE | SUBVENITE |
| 69102-301 | SUBVENITE | SUBVENITE |
| 69102-312 | SUBVENITE | SUBVENITE |
| 69102-300 | SUBVENITE | SUBVENITE |
| 69102-150 | SUBVENITE | SUBVENITE |
| 69102-319 | SUBVENITE | SUBVENITE |
| 69102-320 | SUBVENITE | SUBVENITE |
| 70518-2645 | SUBVENITE | SUBVENITE |
| 0093-0039 | Lamotrigine | Lamotrigine |
| 0093-0132 | Lamotrigine | Lamotrigine |
| 0093-0463 | Lamotrigine | Lamotrigine |
| 0093-0688 | Lamotrigine | Lamotrigine |
| 0093-7247 | Lamotrigine | Lamotrigine |
| 0093-7248 | Lamotrigine | Lamotrigine |
| 0115-1526 | Lamotrigine | LAMOTRIGINE |
| 0115-1527 | Lamotrigine | LAMOTRIGINE |
| 0115-1528 | Lamotrigine | LAMOTRIGINE |
| 0115-1529 | Lamotrigine | LAMOTRIGINE |
| 0115-9939 | Lamotrigine | LAMOTRIGINE |
| 0115-9940 | Lamotrigine | LAMOTRIGINE |
| 0115-9941 | Lamotrigine | LAMOTRIGINE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SUBVENITE 87690016 not registered Live/Pending |
OWP Pharmaceuticals, Inc. 2017-11-17 |